GlassScriptPhysician profile
Lee W Erlendson
NPI 1962429886
$11,325.07
in general payments reported to CMS, 2019-2025
42 companies · $1,636 in 2025
The $1,636 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,613 · 2020: $1,012 · 2021: $1,225 · 2022: $1,843 · 2023: $2,054 · 2024: $941 · 2025: $1,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,635 · Travel and Lodging: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,635.35 |
| Travel and Lodging | $995.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,590.77 | 2019-2024 | Senza |
| Nalu Medical, INC. | $1,194.57 | 2023-2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $1,105.53 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Na |
| Boston Scientific Corporation | $813.41 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Stimwave Technologies Incorporated | $781.97 | 2019-2022 | |
| Spr Therapeutics, INC | $775.55 | 2021-2025 | Sprint Pns System |
| Abbott Laboratories | $758.52 | 2019-2025 | Proclaim |
| Collegium Pharmaceutical, INC. | $666.70 | 2019-2025 | Xtampza, Belbuca |
| Globus Medical, INC. | $446.90 | 2025 | Senza |
| Biohaven Pharmaceuticals, INC. | $301.32 | 2021 | |
| Spinal Simplicity, LLC | $294.23 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $270.77 | 2019-2023 | Xifaxan |
| Medtronic USA, INC. | $261.98 | 2020 | |
| Saluda Medical Americas, INC. | $214.60 | 2023-2025 | Evoke Scs, Evoke |
| Fidia Pharma USA INC. | $146.21 | 2019-2023 | Hymovis |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $140.87 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $134.54 | 2019-2021 | |
| Tersera Therapeutics LLC | $120.84 | 2023-2025 | Prialt |
| Novo Nordisk INC | $118.46 | 2024 | Wegovy |
| Scilex Pharmaceuticals INC. | $110.03 | 2019-2023 | Ztlido |
| Si-Bone, INC. | $109.29 | 2021-2023 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Seqirus USA INC | $92.72 | 2019 | |
| Almatica Pharma LLC | $75.85 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $72.68 | 2022 | |
| West Therapeutics Development, LLC | $64.82 | 2019-2020 | |
| Convatec INC. | $63.07 | 2025 | |
| Averitas Pharma INC. | $61.64 | 2025 | Qutenza |
| Daiichi Sankyo INC. | $61.53 | 2019 | |
| Horizon Therapeutics Plc | $57.38 | 2020-2022 | |
| Pfizer INC. | $51.54 | 2019-2023 | |
| Arbor Pharmaceuticals, INC. | $39.67 | 2021-2022 | |
| Vertiflex, INC. | $35.00 | 2019 | |
| Indivior INC. | $33.35 | 2019-2020 | |
| Protega Pharmaceutials INC | $32.26 | 2025 | Roxybond |
| Vertos Medical, INC. | $29.92 | 2023 | Mild Device Kit |
| Lilly USA, LLC | $22.85 | 2019 | |
| Avanos Medical | $16.42 | 2020 | |
| Amgen INC. | $15.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.55 | 2019 | |
| Redhill Biopharma INC. | $15.28 | 2021 | |
| Shionogi INC | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Erlendson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.